|
1
|
Samowitz WS, Curtin K, Ma KN, Schaffer D,
Coleman LW, Leppert M and Slattery ML: Microsatellite instability
in sporadic colon cancer is associated with an improved prognosis
at the population level. Cancer Epidemiol Biomarkers Prev.
10:917–923. 2001.PubMed/NCBI
|
|
2
|
Stadler ZK: Diagnosis and management of
DNA mismatch repair-deficient colorectal cancer. Hematol Oncol Clin
North Am. 29:29–41. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jacob S and Praz F: DNA mismatch repair
defects: Role in colorectal carcinogenesis. Biochimie. 84:27–47.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Syngal S, Fox EA, Eng C, Kolodner RD and
Garber JE: Sensitivity and specificity of clinical criteria for
hereditary non-polyposis colorectal cancer associated mutations in
MSH2 and MLH1. J Med Genet. 37:641–645. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Taggart MW, Galbincea J, Mansfield PF,
Fournier KF, Royal RE, Overman MJ, Rashid A and Abraham SC:
High-level microsatellite instability in appendiceal carcinomas. Am
J Surg Pathol. 37:1192–1200. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Andersson A, Bergdahl L and Boquist L:
Primary carcinoma of the appendix. Ann Surg. 183:53–57. 1976.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sugarbaker PH: Epithelial appendiceal
neoplasms. Cancer J. 15:225–235. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hananel N, Powsner E and Wolloch Y:
Adenocarcinoma of the appendix: An unusual disease. Eur J Surg.
164:859–862. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Iwuagwu OC, Jameel JK, Drew PJ, Hartley JE
and Monson JR: Primary carcinoma of the appendix-Hull series. Dig
Surg. 22:163–167. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cerame MA: A 25-year review of
adenocarcinoma of the appendix. A frequently perforating carcinoma.
Dis Colon Rectum. 31:145–150. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Turaga KK, Pappas SG and Gamblin T:
Importance of histologic subtype in the staging of appendiceal
tumors. Ann Surg Oncol. 19:1379–1385. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
O'Donnell ME, Badger SA, Beattie GC,
Carson J and Garstin WI: Malignant neoplasms of the appendix. Int J
Colorectal Dis. 22:1239–1248. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Misdraji J and Young RH: Primary
epithelial neoplasms and other epithelial lesions of the appendix
(excluding carcinoid tumors). Semin Diagn Pathol. 21:120–133. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feizi I, Maleki N and Tavosi Z: Mucinous
adenocarcinoma of the appendix. J Res Med Sci. 20:103–104.
2015.PubMed/NCBI
|
|
15
|
Chua TC, Pelz JO and Morris DL: Surgery
for colorectal peritoneal carcinomatosis. Scand J Gastroenterol.
47:277–285. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Varisco B, McAlvin B, Dias J and Franga D:
Adenocarcinoid of the appendix: Is right hemicolectomy necessary? A
meta-analysis of retrospective chart reviews. Am Surg. 70:593–599.
2004.PubMed/NCBI
|
|
17
|
Proulx GM, Willett CG, Daley W and
Shellito PC: Appendiceal carcinoma: Patterns of failure following
surgery and implications for adjuvant therapy. J Surg Oncol.
66:51–53. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
McConnell YJ, Mack LA, Gui X, Carr NJ,
Sideris L, Temple WJ, Dubé P, Chandrakumaran K, Moran BJ and Cecil
TD: Cytoreductive surgery with hyperthermic intraperitoneal
chemotherapy: An emerging treatment option for advanced goblet cell
tumors of the appendix. Ann Surg Oncol. 21:1975–1982. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ung L, Chua TC and David LM: Peritoneal
metastases of lower gastrointestinal tract origin: A comparative
study of patient outcomes following cytoreduction and
intraperitoneal chemotherapy. J Cancer Res Clin Oncol.
139:1899–1908. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nash GM, Smith JD, Tang L, Weiser MR,
Temple LK, O'Reilly E, Saltz LB, Guillem JG and Paty PB: Lymph node
metastasis predicts disease recurrence in a single-center
experience of 70 stages 1–3 appendix cancers: A retrospective
review. Ann Surg Oncol. 22:3613–3617. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Samdani T, Schultheis M, Stadler Z, Shia
J, Fancher T, Misholy J, Weiser MR and Nash GM: Lymph node yield
after colectomy for cancer: Is absence of mismatch repair a factor?
Dis Colon Rectum. 58:288–293. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kelly KJ: Management of appendix cancer.
Clin Colon Rectal Surg. 28:247–255. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ribic CM, Sargent DJ, Moore MJ, Thibodeau
SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R,
Shepherd LE, et al: Tumor microsatellite-instability status as a
predictor of benefit from fluorouracil-based adjuvant chemotherapy
for colon cancer. N Engl J Med. 349:247–257. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carethers JM, Smith EJ, Behling CA, Nguyen
L, Tajima A, Doctolero RT, Cabrera BL, Goel A, Arnold CA, Miyai K
and Boland CR: Use of 5-fluorouracil and survival in patients with
microsatellite-unstable colorectal cancer. Gastroenterology.
126:394–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xie X, Zhou Z, Song Y, Li W, Diao D, Dang
C and Zhang H: The management and prognostic prediction of
adenocarcinoma of appendix. Sci Rep. 6:390272016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Asare EA, Compton CC, Hanna NN, Kosinski
LA, Washington MK, Kakar S, Weiser MR and Overman MJ: The impact of
stage, grade, and mucinous histology on the efficacy of systemic
chemotherapy in adenocarcinomas of the appendix: Analysis of the
National Cancer Data Base. Cancer. 122:213–221. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Glockzin G, Gerken M, Lang SA,
Klinkhammer-Schalke M, Piso P and Schlitt HJ: Oxaliplatin-based
versus irinotecan-based hyperthermic intraperitoneal chemotherapy
(HIPEC) in patients with peritoneal metastasis from appendiceal and
colorectal cancer: A retrospective analysis. BMC Cancer.
14:8072014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Alsaad KO, Serra S, Schmitt A, Perren A
and Chetty R: Cytokeratins 7 and 20 immunoexpression profile in
goblet cell and classical carcinoids of appendix. Endocr Pathol.
18:16–22. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wong SC, Ng SS, Cheung MT, Luk LY, Chan
CM, Cheung AH, Lee VH, Lai PB, Ma BB, Hui EP, et al: Clinical
significance of CDX2-positive circulating tumour cells in
colorectal cancer patients. Br J Cancer. 104:1000–1006. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu Q, Teh M, Ito K, Shah N, Ito Y and
Yeoh KG: CDX2 expression is progressively decreased in human
gastric intestinal metaplasia, dysplasia and cancer. Mod Pathol.
20:1286–1297. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Smyrk TC, Watson P, Kaul K and Lynch HT:
Tumor-infiltrating lymphocytes are a marker for microsatellite
instability in colorectal carcinoma. Cancer. 91:2417–2422. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Arnold CN, Goel A and Boland CR: Role of
hMLH1 promoter hypermethylation in drug resistance to
5-fluorouracil in colorectal cancer cell lines. Int J Cancer.
106:66–73. 2003. View Article : Google Scholar : PubMed/NCBI
|
